Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system

Boron neutron capture therapy (BNCT) for the treatment of unresectable, locally advanced, and recurrent carcinoma of the head and neck cancer has been approved by the Japanese government for reimbursement under the national health insurance as of June 2020. A new treatment planning system for clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Naonori, Tanaka, Hiroki, Kakino, Ryo, Yoshikawa, Syuushi, Miyao, Mamoru, Akita, Kazuhiko, Isohashi, Kayako, Aihara, Teruhito, Nihei, Keiji, Ono, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709965/
https://www.ncbi.nlm.nih.gov/pubmed/34952608
http://dx.doi.org/10.1186/s13014-021-01968-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709965/
https://www.ncbi.nlm.nih.gov/pubmed/34952608
http://dx.doi.org/10.1186/s13014-021-01968-2

Ejemplares similares